ReviewDiscover oncology2024
Anticancer effect of Moringa oleifera in oral squamous cell carcinoma: a systematic review.
Review in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Harnessing the anticancer potential ofAnnals of medicine and surgery (2012) · 2025Article
- Therapeutic potential of curcumin in regenerative dentistry.Frontiers in dental medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveOral squamous cell carcinoma is the most common form of mouth cancer. As plant-based medicines become increasingly popular, Moringa oleifera has been studied extensively for its plant-based components, and health benefits. The present review examined the anticancer effects of Moringa oleifera extracts on Oral squamous cell carcinoma. MATERIALS AND
methodsThe study complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. A comprehensive search was performed on PubMed, Scopus, and Google Scholar to find research papers published from January 2015 to August 2024 that assessed the effects of extracts of various parts of Moringa oleifera in Oral squamous cell carcinoma. Two independent reviewers separately assessed research study titles, abstracts, and the chosen full-text papers. The risk of bias in non-randomized exposure studies was classified as low, with some concerns high and extremely high.
resultsThe final review yielded four in-vitro investigations, two molecular analyses, and five animal models. The study revealed that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemo-preventive properties. All the 11 studies showed a low risk of bias.
conclusionThe studies reviewed herein reveal that Moringa oleifera plant components have antioxidant, anti-inflammatory, anticancer, and chemopreventive properties. Although more clinical trials are needed to fully establish its efficacy and safety as a complementary therapy, the growing body of evidence positions Moringa oleifera as a promising natural adjunct to cancer treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.